Abstract:BackgroundSepsis-associated acute brain inflammation, if unresolved, may cause chronic neuroinflammation and resultant neurodegenerative diseases. However, little is known how the transition from acute to chronic neuroinflammation, which is critical for the following progressive neurodegeneration, occurs in sepsis. The goal of this study was to investigate potential immune factors regulating the transition process using a widely used endotoxemia LPS mouse model. This model shows distinct acute and chronic phases of neuroinflammation and recapitulates many cardinal features of Parkinson's disease, thus, providing a unique opportunity for studying phase transition of neuroinflammation.MethodsC57BL/6J, NLRP3(-/-), and IL-1R1(-/-) mice were employed. Mild and severe endotoxemia were produced by LPS ip injection at 1 or 5 mg/kg. Neuroinflammation in vitro and in vivo was assessed with proinflammatory cytokine expression by qPCR or ELISA and microglial activation by immunohistochemical analysis. Neurodegeneration was measured by manual and stereological counts of nigral dopaminergic neurons and immunohistochemical analysis of protein nitrosylation and alpha-synuclein phosphorylation.ResultsLPS-elicited initial increases in mouse brain mRNA levels of TNF alpha, IL-6, IL-1 beta, and MCP-1, and nigral microglial activation were not dose-related. By contrast, the delayed increase in brain mature IL-1 beta levels was dependent on LPS doses and protracted nigral microglial activation was only observed in high dose of LPS-treated mice. LPS-elicited increase in brain mature IL-1 beta but not IL-1 alpha level was NLRP3-dependent. After high dose LPS treatment, deficiency of NLRP3 or IL-1R1 did not prevent the initiation of acute neuroinflammation but abolished chronic neuroinflammation. Genetic or pharmacological inhibition of the NLRP3-IL-1 beta axis repressed LPS-stimulated upregulation of chronic neuroinflammatory mediators including MHC-II, NOX2, and Mac1, and protected dopaminergic neurons. Ten months after LPS-elicited severe endotoxemia, nigral persisted microglial activation, elevated nitrosylated proteins and phosphorylated alpha-synuclein, and significant neuronal degeneration developed in wild-type mice but not in NLRP3(-/-) or IL-1R1(-/-) mice.ConclusionsThis study uncovers a novel role of the NLRP3-IL-1 beta signaling pathway in gauging the severity of sepsis-associated inflammation and determining whether acute neuroinflammation will resolve or transition to low grade chronic neuroinflammation. These findings also provide novel targets for developing therapy for severe systemic infection-related neurodegeneration.

The Role of Lipopolysaccharide-Induced Cell Signalling in Chronic Inflammation

KEY INFLAMMATORY SIGNALING PATHWAYS ARE REGULATED BY THE PROTEASOME

Lipopolysaccharide sensing an important factor in the innate immune response to Gram-negative bacterial infections: Benefits and hazards of LPS hypersensitivity

The Characteristics and Function of Bacterial Lipopolysaccharides and Their Endotoxic Potential in Humans

The Battle of LPS Clearance in Host Defense vs. Inflammatory Signaling

Lysophospholipid Metabolism Facilitates Toll-like Receptor 4 Membrane Translocation to Regulate the Inflammatory Response

Bacterial lipopolysaccharide-induced endothelial activation and dysfunction: a new predictive and therapeutic paradigm for sepsis

Mechanisms of bacterial lipopolysaccharide-induced endothelial apoptosis

Lipopolysaccharide delivery systems in innate immunity

Chronic Inflammation under the Microscope

Application of lipopolysaccharide in establishing inflammatory models

Lipopolysaccharide-Induced Neuroinflammation as a Bridge to Understand Neurodegeneration

Lipid and Lipoprotein Dysregulation in Sepsis: Clinical and Mechanistic Insights into Chronic Critical Illness

Impact of Periodontal Lipopolysaccharides on Systemic Health: Mechanisms, Clinical Implications, and Future Directions

Molecular mechanisms of innate memory and tolerance to LPS

The Role of Carbohydrates in the Lipopolysaccharide (LPS)/Toll-Like Receptor 4 (TLR4) Signalling

Protective role of phospholipid oxidation products in endotoxin-induced tissue damage

Molecular Mechanisms in Lipopolysaccharide-Induced Pulmonary Endothelial Barrier Dysfunction.

Progression of lipopolysaccharide signal pathway]

A Novel Role of NLRP3-generated IL-1β in the Acute-Chronic Transition of Peripheral Lipopolysaccharide-Elicited Neuroinflammation: Implications for Sepsis-Associated Neurodegeneration

Lipopolysaccharide Signal Transduction, Regulation of Tumor Necrosis Factor Biosynthesis, and Signaling by Tumor Necrosis Factor Itself